http://dbpedia.org/ontology/abstract
|
RTI-229, also known as (–)-3β-(4-iodopheny … RTI-229, also known as (–)-3β-(4-iodophenyl)tropane-2β-pyrrolidine carboxamide and RTI-4229-229, is a potent and long-lasting stimulant drug which was developed in the 1990s as part of a large group of related analogues from the phenyltropane family. With the combination of two potent dopamine transporter (DAT) binding motifs attached to the tropane ring, the p-iodophenyl group at the 3β-position and a pyrrolidine carboxamide at 2β, RTI-229 has extremely high selectivity for the dopamine transporter (2600x and 4600x selective over NET and 5-HTT respectively) and is one of the most DAT-selective compounds in the RTI series.DAT-selective compounds in the RTI series.
|
http://dbpedia.org/ontology/casNumber
|
160948-17-4
|
http://dbpedia.org/ontology/fdaUniiCode
|
4XC2A2NPZ2
|
http://dbpedia.org/ontology/pubchem
|
9910220
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Phenyltropane_28a.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageExternalLink
|
https://painreliefpharmaceuticals.com/generic-adderall/ +
|
http://dbpedia.org/ontology/wikiPageID
|
26034952
|
http://dbpedia.org/ontology/wikiPageLength
|
3820
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1123080154
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Category:Iodoarenes +
, http://dbpedia.org/resource/Category:Dopamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Cocaine +
, http://dbpedia.org/resource/RTI-55 +
, http://dbpedia.org/resource/RTI-121 +
, http://dbpedia.org/resource/Category:Pyrrolidines +
, http://dbpedia.org/resource/Category:Sympathomimetic_amines +
, http://dbpedia.org/resource/Serotonin_transporter +
, http://dbpedia.org/resource/Category:Medical_imaging +
, http://dbpedia.org/resource/Phenyl +
, http://dbpedia.org/resource/Dopamine_transporter +
, http://dbpedia.org/resource/Carboxamide +
, http://dbpedia.org/resource/Category:Stimulants +
, http://dbpedia.org/resource/Dopamine +
, http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Phenyltropane +
, http://dbpedia.org/resource/Category:RTI_compounds +
, http://dbpedia.org/resource/Noradrenaline_transporter +
, http://dbpedia.org/resource/Category:Neuroimaging +
, http://dbpedia.org/resource/Stimulant +
, http://dbpedia.org/resource/Tropane +
, http://dbpedia.org/resource/Category:Tropanes +
, http://dbpedia.org/resource/Iodine +
, http://dbpedia.org/resource/Federal_Analog_Act +
, http://dbpedia.org/resource/Pyrrolidine +
, http://dbpedia.org/resource/List_of_Phenyltropanes +
|
http://dbpedia.org/property/c
|
19
|
http://dbpedia.org/property/casNumber
|
160948
|
http://dbpedia.org/property/h
|
25
|
http://dbpedia.org/property/i
|
1
|
http://dbpedia.org/property/iupacName
|
[-3--8-methyl-8-azabicyclo[3.2.1]octan-2-yl]-pyrrolidin-1-ylmethanone
|
http://dbpedia.org/property/legalStatus
|
Legal
|
http://dbpedia.org/property/n
|
2
|
http://dbpedia.org/property/o
|
1
|
http://dbpedia.org/property/pubchem
|
9910220
|
http://dbpedia.org/property/smiles
|
CN1[C@H]2CC[C@@H]1[C@H]CN4CCCC4
|
http://dbpedia.org/property/unii
|
4
|
http://dbpedia.org/property/verifiedrevid
|
451551869
|
http://dbpedia.org/property/width
|
200
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Monoamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Template:Stimulants +
, http://dbpedia.org/resource/Template:Use_dmy_dates +
, http://dbpedia.org/resource/Template:Fdacite +
, http://dbpedia.org/resource/Template:Drugbox +
, http://dbpedia.org/resource/Template:Phenyltropanes +
, http://dbpedia.org/resource/Template:Short_description +
, http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Cascite +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Carboxamides +
, http://dbpedia.org/resource/Category:RTI_compounds +
, http://dbpedia.org/resource/Category:Medical_imaging +
, http://dbpedia.org/resource/Category:Neuroimaging +
, http://dbpedia.org/resource/Category:Pyrrolidines +
, http://dbpedia.org/resource/Category:Sympathomimetic_amines +
, http://dbpedia.org/resource/Category:Dopamine_reuptake_inhibitors +
, http://dbpedia.org/resource/Category:Stimulants +
, http://dbpedia.org/resource/Category:Tropanes +
, http://dbpedia.org/resource/Category:Iodoarenes +
|
http://purl.org/linguistics/gold/hypernym
|
http://dbpedia.org/resource/Drug +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/RTI-229?oldid=1123080154&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Phenyltropane_28a.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/RTI-229 +
|
owl:sameAs |
http://sr.dbpedia.org/resource/RTI-229 +
, http://dbpedia.org/resource/RTI-229 +
, http://www.wikidata.org/entity/Q7277832 +
, https://global.dbpedia.org/id/4ty6s +
, http://rdf.freebase.com/ns/m.0b6jrkz +
, http://sh.dbpedia.org/resource/RTI-229 +
, http://yago-knowledge.org/resource/RTI-229 +
|
rdf:type |
http://dbpedia.org/class/yago/WikicatRTICompounds +
, http://dbpedia.org/class/yago/PsychologicalFeature100023100 +
, http://dbpedia.org/class/yago/Cognition100023271 +
, http://dbpedia.org/class/yago/Matter100020827 +
, http://dbpedia.org/class/yago/Whole105869584 +
, http://dbpedia.org/class/yago/OrganicCompound114727670 +
, http://dbpedia.org/class/yago/Material114580897 +
, http://dbpedia.org/class/yago/Compound105870180 +
, http://dbpedia.org/class/yago/Compound114818238 +
, http://dbpedia.org/class/yago/Idea105833840 +
, http://dbpedia.org/class/yago/Chemical114806838 +
, http://dbpedia.org/class/yago/Content105809192 +
, http://dbpedia.org/class/yago/Substance100019613 +
, http://dbpedia.org/class/yago/WikicatAmides +
, http://dbpedia.org/class/yago/Amine114739004 +
, http://dbpedia.org/class/yago/Amide114724264 +
, http://dbpedia.org/class/yago/WikicatStimulants +
, http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/MethaneSeries114951377 +
, http://dbpedia.org/class/yago/Stimulation105827684 +
, http://dbpedia.org/class/yago/Information105816287 +
, http://dbpedia.org/class/yago/Concept105835747 +
, http://www.wikidata.org/entity/Q8386 +
, http://dbpedia.org/ontology/Drug +
, http://dbpedia.org/class/yago/PhysicalEntity100001930 +
, http://dbpedia.org/class/yago/WikicatSympathomimeticAmines +
, http://dbpedia.org/class/yago/Relation100031921 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
, http://dbpedia.org/class/yago/AliphaticCompound114601294 +
, http://dbpedia.org/class/yago/Part113809207 +
|
rdfs:comment |
RTI-229, also known as (–)-3β-(4-iodopheny … RTI-229, also known as (–)-3β-(4-iodophenyl)tropane-2β-pyrrolidine carboxamide and RTI-4229-229, is a potent and long-lasting stimulant drug which was developed in the 1990s as part of a large group of related analogues from the phenyltropane family. With the combination of two potent dopamine transporter (DAT) binding motifs attached to the tropane ring, the p-iodophenyl group at the 3β-position and a pyrrolidine carboxamide at 2β, RTI-229 has extremely high selectivity for the dopamine transporter (2600x and 4600x selective over NET and 5-HTT respectively) and is one of the most DAT-selective compounds in the RTI series.DAT-selective compounds in the RTI series.
|
rdfs:label |
RTI-229
|